Obesity and Multiple Myeloma: What Do the Data Tell Us?

Rafael Rios Tamayo^1,2*, Juan Sáinz Perez^1,2, Jose Juan Jimenez-Moleon^3,4 and Manuel Jurado Chacon^1,2

¹Monoclonal Gammopathies Unit, University Hospital Virgen de las Nieves, Granada, Spain

²Genomic Oncology Area, Genyo (Pfizer-University of Granada-Andalusian Government Centre for Genomics and Oncological Research), Granada, Spain

³CIBER Epidemiology and Public Health, Granada, Spain

⁴Department of Preventive Medicine and Public Health, University of Granada, Granada, Spain

^*Corresponding Author: Rafael Rios Tamayo, Monoclonal Gammopathies Unit, University Hospital Virgen de las Nieves, Granada, Spain, Genomic Oncology Area, Genyo (Pfizer-University of Granada-Andalusian Government Centre for Genomics and Oncological Research), Granada, Spain, Tel: +34 671592298, Fax: +34 958020655 Email: